Federal regulators want most patients to see a health care provider in person before receiving prescriptions for potentially addictive medicines through telehealth—something that hasn’t been required in more than three years.
During the COVID-19 public health emergency, the Drug Enforcement Administration allowed doctors and other health care providers to prescribe controlled medicine during telehealth appointments without examining the patient in person. The emergency declaration ended May 13, and in February, the agency proposed new rules that would require providers to see patients at least once in person before prescribing many of those drugs during telehealth visits.
